Breckenridge Pharm Company Profile

What is the competitive landscape for BRECKENRIDGE PHARM, and what generic and branded alternatives to BRECKENRIDGE PHARM drugs are available?

BRECKENRIDGE PHARM has five approved drugs.

Summary for Breckenridge Pharm

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	5
PTAB Cases with Breckenridge Pharm as petitioner:	See PTAB cases with Breckenridge Pharm as petitioner

Drugs and US Patents for Breckenridge Pharm

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Breckenridge Pharm	METHSCOPOLAMINE BROMIDE	methscopolamine bromide	TABLET;ORAL	040642-001	Dec 6, 2011	AA	RX	No	No
Breckenridge Pharm	METHSCOPOLAMINE BROMIDE	methscopolamine bromide	TABLET;ORAL	040642-002	Dec 6, 2011	AA	RX	No	No
Breckenridge Pharm	POLYETHYLENE GLYCOL 3350	polyethylene glycol 3350	FOR SOLUTION;ORAL	077736-001	May 26, 2006		DISCN	No	No
Breckenridge Pharm	OXCARBAZEPINE	oxcarbazepine	TABLET;ORAL	078069-001	Jan 11, 2008	AB	RX	No	No
Breckenridge Pharm	ESTRADIOL AND NORETHINDRONE ACETATE	estradiol; norethindrone acetate	TABLET;ORAL	078324-001	Apr 17, 2008	AB	RX	No	No
Breckenridge Pharm	OXCARBAZEPINE	oxcarbazepine	TABLET;ORAL	078069-003	Jan 11, 2008	AB	RX	No	No
Breckenridge Pharm	OXCARBAZEPINE	oxcarbazepine	TABLET;ORAL	078069-002	Jan 11, 2008	AB	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Breckenridge
• Breckenridge Pharm